用多价值谷氨酸六胺修改的脂质体:一种新且有效的方法来促进骨的向
Yi Zhao1, Yang Yang1, Yamin Cui2
1Department of Translational Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Archiv der Pharmazie
|December 22, 2023
概括
新型基改性脂质体有效地将帕克利塔塞尔 (PTX) 输送到骨,增强癌症治疗. 在评估中,PTX-Glu65-Lip表现出优越的骨准和抗转移效应.
科学领域:
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
- 纳米技术 纳米技术
背景情况:
- 与骨相关的疾病由于血液 perfusion 差,造成治疗挑战.
- 针对性地向骨输送药物可以提高疗效并减少全身毒性.
- 帕克利塔克塞尔 (PTX) 是一种强效的化疗剂,具有有限的骨透率.
研究的目的:
- 设计和合成用于骨向脂体的新配体.
- 开发带有帕克利塔塞尔 (PTX) 的脂质体,具有增强的骨准能力.
- 评估这些向性脂质体对骨转移的体外和体内疗效.
主要方法:
- 合成多价值的谷六衍生物作为脂质体连接体.
- 准备和描述带有PTX的脂质体 (封装效率,颗粒大小,稳定性,泽塔潜力,血液溶解,释放动力学).
- 在体外和体内评估改性脂质体的骨向导活性和抗转移效果.
主要成果:
- 新型质功能化脂质体成功封装了PTX.
- 涂有Glu61,Glu62,Glu63和Glu65的脂质体表现出显著的骨准潜力.
- 与其他配方相比,PTX-Glu65-Lip表现出优越的骨定位和强大的抗骨转移活性.
- 鉴定证实了有利的脂质体特性,包括稳定性和受控释放.
结论:
- 多价格的谷氨酸六衍生物是针对骨的脂质体的有效配体.
- PTX-Glu65-Lip代表了一种有前途的战略,用于针对性地向骨输送化疗.
- 这种方法有可能改善骨转移和相关疾病的治疗.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


